Failure of cyclosporin a to rescue peripheral nerve allografts in acute rejection

Annals of Plastic Surgery

Volumn 49, Issue 6, 2002, Pages 660-667

  Chen, Delphine L ^a   Mackinnon, Susan E ^a   Jensen, John N ^a   Hunter, Daniel A ^a   Grand, Aaron G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MIXED LYMPHOCYTE REACTION; NERVE GRAFT; NERVE TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0036894052     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-200212000-00017     Document Type: Article

References (28)

1. Fish JS, Bain JR, McKee NH, et al. The peripheral nerve allograft in the primate immunosuppressed with cyclosporin A: II. Functional evaluation of reinnervated muscle. Plast Reconstr Surg 1992;90:1047-1052
2. Bain JR, Mackinnon SE, Hudson AR, et al. The peripheral nerve allograft: An assessment of regeneration across nerve allografts in rats immunosuppressed with cyclosporin A. Plast Reconstr Surg 1988;82:1052-1066
3. Bain JR, Mackinnon SE, Hudson AR, et al. The peripheral nerve allograft in the primate immunosuppressed with cyclosporin A: I. Histologic and electrophysiologic assessment. Plast Reconstr Surg 1992;90:1036-1046
4. Mackinnon SE, Hudson AR, Bain JR, et al. The peripheral nerve allograft: An assessment of regeneration in the immunosuppressed host. Plast Reconstr Surg 1987;79:436-446
5. Mackinnon SE, Midha R, Bain J, et al. An assessment of regeneration across peripheral nerve allografts in rats receiving short courses of cyclosporin A immunosuppression. Neuroscience 1992;46:585-593
6. Yu LT, England J, Hickey WF, et al. Survival and function of peripheral nerve allografts after cessation of long-term cyclosporin immunosuppression in rats. Transplant Proc 1989;21:3178-3180
7. Ghoneim MA, Sobh MA, Shokeir AA, et al. Cyclosporin in primary haploidentical live-donor kidney transplantation: Is it worthwhile? Nephrol Dial Transplant 1993;8:551-556
8. Ghoneim MA, Sobh MA, Shokeir AA, et al. Prospective randomized study of azathioprine versus cyclosporin in live-donor kidney transplantation. Am J Nephrol 1993;13:437-441
9. Iacono AT, Keenan RJ, Duncan SR, et al. Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am J Respir Crit Care Med 1996;153:1451-1455
10. Keenan RJ, Iacono A, Dauber JH, et al. Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients. J Thorac Cardiovasc Surg 1997;113:335-340
11. Bain JR, Mackinnon SE, Hudson AR, et al. The peripheral nerve allograft: A dose-response curve in the rat immunosuppressed with cyclosporin A. Plast Reconstr Surg 1988;82:447-457
12. Midha R, Mackinnon SE, Evans PJ, et al. Subcutaneous injection of oral cyclosporin A solution. Microsurgery 1992;13:92-94
13. Nakafusa Y, Terasaka R, Matsuo K, et al. Advantages of donor-specific blood transfusion in the rat via the portal vein for renal transplantation. Am J Kidney Dis 1993;21:433-438
14. Zalewski AA, Azzam NA, Azzam RN. The loss of regenerated host axons in nerve allografts after stopping immunosuppression with cyclosporin A is related to immune effects on allogeneic Schwann cells. Exp Neurol 1995;133:189-197
15. Midha R, Mackinnon SE, Evans PJ, et al. Comparison of regeneration across nerve allografts with temporary or continuous cyclosporin A immunosuppression. J Neurosurg 1993;78:90-100
16. Ishida O, Daves J, Tsai TM, et al. Regeneration following rejection of peripheral nerve allografts of rats on withdrawal of cyclosporine. Plast Reconstr Surg 1993;92:916-926
17. Frazier J, Yu L, Rhee E, et al. Extended survival and function of peripheral nerve allografts after cessation of long-term cyclosporin administration in rats. J Hand Surg [Am] 1993;18:100-106
18. Midha R, Evans PJ, Mackinnon SE, et al. Temporary immunosuppression for peripheral nerve allografts. Transplant Proc 1993;25:532-536
19. Haydon GH, Hayes PC. New immunosuppressive treatment in transplantation medicine [review]. Baillieres Clin Gastroenterol 1994;8:455-464
20. Mackinnon SE, Doolabh VB, Novak CB, et al. Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg 2001;107:1419-1429
21. Pollard JD, Fitzpatrick L. An ultrastructural comparison of peripheral nerve allografts and autografts. Acta Neuropathol (Berl) 1973;23:152-165
22. Verhoog BD, Bekkum, DV. Peripheral nerve allografts: Modifications of allograft reaction using experimental model in rats. Transplant Proc 1971;3:591-593
23. Comtet JJ, Revillard JP. Peripheral nerve allografts. I. Distinctive histological features of nerve degeneration and immunological rejection. Transplantation 1979;28:103-106
24. Selzner N, Durand F, Bernuuau J, et al. Conversion from cyclosporine to FK506 in adult liver transplant recipients: A combined North American and European experience. Transplantation 2001;72:1061-1065
25. Hymes LC, Warshaw BL. Tacrolimus rescue therapy for children with acute renal transplant rejection. Pediatr Nephrol 2001;16:990-992
26. DeBonis M, Reynolds L, Barros J, et al. Tacrolimus as a rescue immunosuppressant after heart transplantation. Eur J Cardiothorac Surg 2001;19:690-695
27. Vitulo P, Oggionni T, Cascina A, et al. Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation. J Heart Lung Transplant 2002;21:435-439
28. Feng FY, Ogden MA, Myckatyn TM, et al. FK506 rescues peripheral nerve allografts in acute rejection. J Neurotrauma 2001;18:217-29